J CLIN ONCOL 2019 10.1200/JCO.19.00016
Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial
Hong1, YS; Kim, SY; Lee, JS; Nam, BH; Kim, KP; Kim, JE; Park, YS; Park, JO; Baek, JY; Kim, TY; Lee, KW; Ahn, JB; Lim, SB; Yu, CS; Kim, JC; Yun, SH; Kim, JH; Park, JH; Park, HC; Jung, KH; Kim, TW

Cancer Med 2019 10.1002/cam4.2570
Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma
Yu1, JI; Lee, SJ; Lee, J; Lim, HY; Paik, SW; Yoo, GS; Choi, C; Park, HC

SCI REP-UK 2019 10.1038/s41598-019-50594-2
Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma
Ha1, SY; Yu, JI; Choi, C; Kang, S; Joh, JW; Paik, SW; Kim, S; Kim, M; Park, HC; Park, CK

J APPL CLIN MED PHYS 2019 10.1002/acm2.12718
Feasibility of a GATE Monte Carlo platform in a clinical pretreatment QA system for VMAT treatment plans using TrueBeam with an HD120 multileaf collimator
Lee1, B; Jeong, S; Chung, K; Yoon, M; Park, HC; Han, Y; Jung, SH

CANCER RES TREAT 2019 10.4143/crt.2018.687
Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B Korea (KROG 16-05)
Bae1, SH; Park, HC; Yoon, WS; Yoon, SM; Jung, IN; Lee, IJ; Kim, JW; Seong, J; Kim, TH; Nam, TK; Choi, Y; Lee, SY; Jang, HS; Lee, DS; Kim, JH

TUMORI 2019 10.1177/0300891618792476
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy
Kim1, TG; Park, W; Kim, H; Choi, DH; Park, HC; Kim, SH; Cho, YB; Yun, SH; Kim, HC; Lee, WY; Lee, J; Kang, KM

INT J MOL SCI 2019 10.3390/ijms20174297
NOD2 Supports Crypt Survival and Epithelial Regeneration after Radiation-Induced Injury
Lee1, C; Choi, C; Kang, HS; Shin, SW; Kim, SY; Park, HC; Hong, SN

ACTA RADIOL 2019 10.1177/0284185118805253
Evaluation of early treatment response to radiotherapy for HCC using pre- and post-treatment MRI
Song1, SH; Jeong, WK; Choi, D; Kim, YK; Park, HC; Yu, JI

PLoS One 2019 10.1371/journal.pone.0218049
Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction
Choi1, C; Son, A; Lee, GH; Shin, SW; Park, S; Ahn, SH; Chung, Y; Yu, JI; Park, HC

WORLD J GASTROENTERO 2019 10.3748/wjg.v25.i20.2416
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
Choi1, C; Yoo, GS; Cho, WK; Park, HC

ANN SURG 2019 10.1097/SLA.0000000000002582
Anastomotic Leak Does Not Impact Oncologic Outcomes After Preoperative Chemoradiotherapy and Resection for Rectal Cancer
Jang1, JH; Kim, HC; Huh, JW; Park, YA; Cho, YB; Yun, SH; Lee, WY; Yu, JI; Park, HC; Park, YS; Park, JO

INT J MOL SCI 2019 10.3390/ijms20081894
Comparison of Proton and Photon Beam Irradiation in Radiation-Induced Intestinal Injury Using a Mouse Model
Choi1, C; Lee, C; Shin, SW; Kim, SY; Hong, SN; Park, HC

J RADIAT RES 2019 10.1093/jrr/rry102
Concurrent chemo-radiotherapy for unresectable non-small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe?
Yoo1, GS; Oh, D; Pyo, H; Ahn, YC; Noh, JM; Park, HC; Lim, DH

SURGERY 2019 10.1016/j.surg.2018.08.026
Tumor regression grade as a clinically useful outcome predictor in patients with rectal cancer after preoperative chemoradiotherapy
Huh1, JW; Kim, HC; Kim, SH; Park, YA; Cho, YB; Yun, SH; Lee, WY; Park, HC; Choi, DH; Park, JO; Park, YS; Chun, HK

PLoS One 2019 10.1371/journal.pone.0210730
Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW

MAR DRUGS 2018 10.3390/md16120510
Fucoidan-Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Co-Targeting Tumor Hypoxia and Angiogenesis
Shin1, SW; Jung, W; Choi, C; Kim, SY; Son, A; Kim, H; Lee, N; Park, HC

Ann Transl Med 2018 10.21037/atm.2018.08.28
Local modalities for inoperable hepatocellular carcinoma: radiofrequency ablation versus stereotactic body radiotherapy
Bae1, SH; Park, HC

J GASTROINTEST SURG 2018 10.1007/s11605-018-3815-9
Prognostic Role of Carcinoembryonic Antigen Level after Preoperative Chemoradiotherapy in Patients with Rectal Cancer
Huh1, JW; Yun, SH; Kim, SH; Park, YA; Cho, YB; Kim, HC; Lee, WY; Park, HC; Choi, DH; Park, JO; Park, YS; Chun, HK

ANTICANCER RES 2018 10.21873/anticanres.12808
Treatment of Naive HCC Combined with Segmental or Subsegmental Portal Vein Tumor Thrombosis: Liver Resection Versus TACE Followed by Radiotherapy
Yu1, JI; Choi, GS; Lim, DH; Lee, E; Joh, JW; Kwon, CHD; Kim, JM; Kim, S; Woo, SY; Paik, SW; Park, HC

CANCER RES TREAT 2018 10.4143/crt.2017.252
The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma
Lee1, SW; Lee, JH; Lee, IK; Oh, ST; Kim, DY; Kim, TH; Oh, JH; Baek, JY; Chang, HJ; Park, HC; Kim, HC; Chie, EK; Nam, TK; Jang, HS